The Harvard Embryonic Stem Cell Research Oversight (the “ESCRO”) Committee, an ethics oversight committee charged with reviewing research protocols involving human embryos, human embryonic stem cells, and certain activities with non-embryonic human pluripotent stem cells, recently issued a report exploring the ethical issues related to the creation of synthetic human embryos

Quick Read

Revising the Genome

December 4, 2017

CRISPR lets scientists edit our genetic source code. This is going to be interesting. With comments from our Debra Mathews

Quick Read

Ethics guidance on priorities, inclusion, and evidence generation – enriched with additional links and resources, and broken into expandable sections for ease of reading and reference

Quick Read

The government doesn’t want to stand in the way of autonomous vehicles. That’s the biggest message to emerge from the Trump administration’s newly updated guidelines for the nascent robo-car industry.

Quick Read

For the first time in human existence, it became practical to change genes throughout the entire human genome with high precision and accuracy. And today, a decade after the introduction of CRISPR, it’s newly apparent that such manipulations have been made to human embryos — a feat achieved by scientists at the Salk Institute in La Jolla and elsewhere

Quick Read

After a brief winter respite, concern over the virus is returning with a vengeance. Scientists continue to work to get ahead of the virus, and some are hoping to test vaccines on pregnant women for some surprising reasons

Quick Read

An ethics group stresses the importance of including the disease’s most vulnerable population in clinical trials

Quick Read

Scientific American’s Editors write, “partnering across borders means faster discovery and a safer world”

Quick Read